Compare PRPO & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPO | MIND |
|---|---|---|
| Founded | N/A | 1987 |
| Country | United States | United States |
| Employees | N/A | 157 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Industrial Machinery/Components |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.1M | 45.8M |
| IPO Year | 2000 | N/A |
| Metric | PRPO | MIND |
|---|---|---|
| Price | $24.10 | $5.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 100.4K | 75.6K |
| Earning Date | 05-12-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.15 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $24,049,000.00 | N/A |
| Revenue This Year | N/A | $23.31 |
| Revenue Next Year | N/A | $1.01 |
| P/E Ratio | ★ N/A | $22.27 |
| Revenue Growth | ★ 29.77 | N/A |
| 52 Week Low | $13.80 | $4.66 |
| 52 Week High | $33.63 | $14.50 |
| Indicator | PRPO | MIND |
|---|---|---|
| Relative Strength Index (RSI) | 50.87 | 46.91 |
| Support Level | $22.36 | $4.80 |
| Resistance Level | $25.27 | $9.19 |
| Average True Range (ATR) | 1.59 | 0.34 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 76.67 | 33.33 |
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in single segment namely, Seamap which provides services and products, including engineering, repairs and software licensing, utilized in marine exploration, marine survey and maritime security for marine survey companies, seismic survey contractors, research institutes, non-military government organizations and operators of port facilities and other offshore installations. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.